2’-Fucosyllactose: Allergy Symptom Modulation of HMOs
|Location:||Glasgow, Scotland, United Kingdom|
In this 2:47 min interview, Dr. Ardythe Morrow, PhD, discusses 2’-Fucosyllactose, a human milk oligosaccharide (HMO). Dr Morrow first presented this material at ESPGHAN 2019 in June 2019.
Ardythe Morrow, PhD
Dr. Ardythe Morrow earned her Master of Science in nutrition from the University of the West Indies in Kingston, Jamaica. While at the University of the West Indies, Dr. Morrow studied infant nutrition and child health. Dr. Morrow completed her Doctor of Philosophy from the University of Texas at Houston in epidemiology. Following her graduate and postgraduate training, Dr. Morrow has written more than 160 publications on infant nutrition and child health and is regarded as a leading expert in human milk composition. Over her career, Dr. Morrow has published extensively on breastfeeding promotion and human milk protection against infectious disease. She has been awarded more than $25 million in grants from NIH, CDC, industry, and foundations and has served as President of the International Society for Research in human milk and lactation. Dr. Morrow has published extensively on breastfeeding promotion and human milk protection against infectious diseases. Currently, Dr. Morrow is the Director at the Center for Interdisciplinary Research in Human Milk and Lactation Global Health Center. Additionally, Dr. Morrow serves as a Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center where she founded and directs the Center for Epidemiology and Biostatistics.